The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transrectal Ultrasound-guided (TRUS) Prostate Biopsy

• Status: Enrolling by invitation
• Trial end date: 2023-09-01
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this study is to evaluate the therapeutic efficacy of tamsulosin and tadalafil compared to placebo in the treatment and prevention of urinary disorders after transrectal ultrasound-guided (TRUS) prostate biopsy

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Hospital of Split
• Treatments: Ascorbic Acid; Tadalafil; Tamsulosin

Criteria

Inclusion Criteria:

• Every patient that is a candidate for first time TRUS biopsy

Exclusion Criteria:

• previous complaints of the lower urinary tract; benign prostatic hyperplasia(BPH), overactive bladder (OAB), etc.

• previous urinary retention and catheterization

• previous TRUS biopsies

• patients who were treated surgically or medically for BPH

• systemic diseases including uncontrolled diabetes

• neurological diseases

• hemorrhagic diathesis

• patients on anticoagulants therapy

• patients with urinary infections